AMW Further Strengthens Executive Leadership Team by Appointing Dr. Joerg Serafimov as Chief Business Officer
Warngau, Germany, January 9, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed to the newly created role as Chief Business Officer (CBO), effective January 1, 2024. In this capacity, he is responsible for International Business and Licensing, Key Account Management, […]
read more